Back to search results
NCT07518238

Hernia Abd Wall Recons - BDE vs Exparel

Enrolling by Invitation
PHASE2Ages 18+InterventionalTreatment
Baylor Research Institute
~128 participants
Updated 2026-04-08 on ClinicalTrials.gov
What's tested:BDE Injectable DrugExparel Injectable Drug

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Morphine Milligram Equivalent
Measured over Post-Op day 1, 2, 3, 4 and 2 Week Follow-up (Day 14)
+2 more outcomes measured

Conditions

BDE for Hernia Patients
Exparel for Hernia Patients

Explore related trials

Hernia

Where it's being run

1 sites across 1 states
Texas1

Study leadership

  • Bola Aladegbami, MD · PRINCIPAL_INVESTIGATOR · Baylor Scott and White Health

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Any preoperative robotic and open abdominal wall surgery patient who will receive a transversus Abdominis Plane (TAP) block in the BSW health care system who agrees to participate in the study
Patients 18 years and above

Exclusion

Patients not undergoing abdominal wall reconstruction surgery
Pregnant patients- Patients with childbearing potential undergo serum pregnancy test as per standard of care pre-procedure. If they are found to test positive, they will be excluded from the study.
Patients less than 18 years old
Patients receiving any additional regional anesthesia outside the study protocol prior to surgery.
Patients undergoing additional planned surgical procedures during the same admission
History of chronic pain or chronic opioid use Known allergy to BDE or Exparel or to drugs included as part of multimodal regimen { acetaminophen, gabapentin or Lyrica (pregabalin)}.

What this trial measures

  • Morphine Milligram EquivalentPost-Op day 1, 2, 3, 4 and 2 Week Follow-up (Day 14)

    To evaluate the difference in medication usage/ Morphine Milligram Equivalent (MME) between the two groups

  • Pain controlBaseline, Surgery Day, Post-Op day 1, 2, 3, 4 and 2 Week Follow-up (Day 14)

    Compre efficacy in pain control by using the PNRS Questionniare

  • Hospital Stay30-45 days after hospital discharge

    To compare the length of hospital, stay between patients receiving BDE and those receiving Exparel.